Sex difference in platelet aggregation detected by new aggregometry using light scattering

Endocrine Journal

Volumn 48, Issue 1, 2001, Pages 33-41

  Haque, S F ^a   Matsubayashi, H ^a   Izumi, S I ^a   Sugi, T ^a   Arai, T ^a   Kondo, A ^a   Makino, T ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Estradiol; Female; Male; Platelet; Testosterone

Indexed keywords

ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; FOLLICULAR PHASE; HORMONE SUBSTITUTION; HUMAN; HYPERCOAGULABILITY; LIGHT SCATTERING; MALE; MENSTRUATION; OVARY HYPERSTIMULATION; SEX DIFFERENCE; STIMULUS RESPONSE; SUBSTITUTION THERAPY; THROMBOCYTE AGGREGATION;

EID: 0035083637     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.33     Document Type: Article

References (31)

1. Platelet aggregometry: Methods and issues
2. Sex difference of platelet aggregation in acute stage cerebral infarction
3. Sex related differences in platelet function: The effect of aspirin
4. Platelet aggregometry
5. New aggregometry using light scattering
6. Platelet aggregation in acute coronary syndromes: Use of a new aggregometry with laser scattering to assess platelet aggregability
7. Development of large platelet aggregates from small aggregates as determined by laserlight scattering: Effects of aggregant concentration and antiplatelet medication
8. Incidence of severe ovarian hyperstimulation syndrome with extremely elevated serum estrogen levels
9. The ovarian hyperstimulation syndrome in in-vitro fertilization; a Belgian multicentric study. I. Clinical and biological features
10. Subclavian vein thrombosis; a late complication of ovarian hyperstimulation syndrome
11. Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis
12. The ovarian hyper-stimulation syndrome
13. Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women
14. Estrogen use and cardiovascular disease
15. Hormone replacement therapy: Cardiovascular benefits for aging women
16. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
17. Decreased mortality in users of estrogen replacement therapy
18. Stroke prevention and oestrogen replacement therapy
19. Haemostatic changes and the oral contraceptive pill
20. Effects of oral contraceptives containing 50 microgram estrogen on blood coagulation in non-Caucasian women
21. Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives
22. Population-based study of risk of venous thromboembolism associated with oral contraceptives
23. Third-generation oral contraceptives and venous thrombosis
24. Oral contraceptives and venous thromboembolism
25. Venothromboembolism. Cardiovascular disease and steroid hormone contraception
26. Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion
27. Molecular mechanisms of platelet activation
28. 2 after low-dose aspirin
29. A randomized trial of aspirin and sulfinpyrazone in threatened stroke
30. Sex difference in antithrombotic effect of aspirin
31. Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17-alpha hydroxylase, 17, 20-lyase deficiency: What is the role of oestrogens?